Status | Study |
Recruiting |
Study Name: A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study Condition: Dysentery, Bacillary Date: 2017-03-21 Interventions: Biological: GVGH Shigella sonnei 1790GAHB vaccine Single dose administered at Day 1, by intramuscular in |
Not yet recruiting |
Study Name: Safety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in Adults Condition: Shigella Sonnei Dysenteries Date: 2017-01-23 Interventions: Biological: Shigella flexneri 2a whole cell (Sf2aWC) vaccine and double muta |
Not yet recruiting |
Study Name: Shigella Sonnei 53G Challenge Condition: Healthy Date: 2016-06-24 Interventions: Biological: Shigella sonnei 53G |
Not yet recruiting |
Study Name: SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers Condition: Shigellosis Bacillary Dysentery Date: 2016-04-18 Interventions: Biological: SF2a-TT15 vaccine Biological: |
Recruiting |
Study Name: Auranofin Trial for GI Protozoa Condition: Amoebic Dysentery Giardiasis Date: 2016-04-07 Interventions: Drug: Auranofin Auranofin is a |
Completed |
Study Name: A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults Condition: Shigella Sonnei Infection Date: 2016-02-01 Interventions: Biological: S. sonnei vaccine 25 μg |
Active, not recruiting |
Study Name: Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a Condition: Shigellosis Date: 2015-12-23 Interventions: Biological: Flexyn2a 2 doses o |
Active, not recruiting |
Study Name: Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR) Administered Intranasally to Healthy, Adult Volunteers Condition: Shigellosis Bacillary Dysentery Date: 2015-05-13 Interventions: Biological: Shigella flexneri 2a InvaplexAR The investigational product is S. flexneri 2a InvaplexAR. Th |
Completed |
Study Name: Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a Condition: Shigellosis Date: 2015-02-23 Interventions: Biological: Flexyn2a Intramusc |
Completed |
Study Name: Efficacy of Rifaximin in Preventing Campylobacteriosis Condition: Dysentery Diarrhea Enteric Ca Date: 2014-10-29 Interventions: Biological: Challenge with C. jejuni Challenge with C jejuni |